{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T03:23:09Z","timestamp":1784517789898,"version":"3.55.0"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.3817","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:34:10Z","timestamp":1558092850000},"page":"e193817","source":"Crossref","is-referenced-by-count":30,"title":["Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan"],"prefix":"10.1001","volume":"2","author":[{"given":"Toyoaki","family":"Sawano","sequence":"first","affiliation":[{"name":"Department of Surgery, Minamisoma Municipal General Hospital, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan"},{"name":"Medical Governance Research Institute, Shinagawa, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Minamisoma Municipal General Hospital, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Medical Governance Research Institute, Shinagawa, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"9896","key":"zoi190168r2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(13)61933-9","article-title":"Research misconduct and scientific integrity: a call for a global forum.","volume":"382","author":"Tanimoto","year":"2013","journal-title":"Lancet"},{"issue":"20","key":"zoi190168r3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/eurheartj\/ehp363","article-title":"Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study","volume":"30","author":"Sawada","year":"2009","journal-title":"Eur Heart J"},{"issue":"9571","key":"zoi190168r4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0140-6736(07)60669-2","article-title":"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study","volume":"369","author":"Mochizuki","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"zoi190168r5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2337\/dc06-2493","article-title":"Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART)","volume":"30","author":"Uzu","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi190168r6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/hr.2010.186","article-title":"Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial","volume":"34","author":"Narumi","year":"2011","journal-title":"Hypertens Res"},{"issue":"3","key":"zoi190168r7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.111.184226","article-title":"Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study","volume":"59","author":"Muramatsu","year":"2012","journal-title":"Hypertension"},{"issue":"8","key":"zoi190168r13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1001\/jamainternmed.2016.2765","article-title":"Pharmaceutical industry-sponsored meals and physician prescribing patterns for Medicare beneficiaries.","volume":"176","author":"DeJong","year":"2016","journal-title":"JAMA Intern Med"},{"key":"zoi190168r14","doi-asserted-by":"publisher","first-page":"i4189","DOI":"10.1136\/bmj.i4189","article-title":"Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.","volume":"354","author":"Fleischman","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"zoi190168r15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jamainternmed.2016.1709","article-title":"Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts.","volume":"176","author":"Yeh","year":"2016","journal-title":"JAMA Intern Med"},{"key":"zoi190168r1","volume-title":"Conflict of Interest in Medical Research, Education, and Practice","author":"Lo","year":"2009"},{"key":"zoi190168r8","unstructured":"Japan Pharmaceutical Manufacturers Association. Transparency guideline for relationships between physicians and pharmaceutical industry [in Japanese]. http:\/\/www.jpma.or.jp\/tomeisei\/index.html. Accessed March 10, 2019."},{"key":"zoi190168r9","unstructured":"Research and non-research payments to physicians from pharmaceutical industry in 2012 [in Japanese]. Weekly Diamond. https:\/\/diamond.jp\/articles\/-\/42339. Accessed April 12, 2019."},{"key":"zoi190168r10","unstructured":"Novartis. Information about pharmaceutical payments to physicians and self-help patient group from Novartis [in Japanese]. https:\/\/www.novartis.co.jp\/about-us\/corporate-responsibility\/transparency\/agreement-transparency. Accessed March 10, 2019."},{"key":"zoi190168r11","unstructured":"Answer News. The world ranking of pharma company by drug sales in 2017 [in Japanese.] https:\/\/answers.ten-navi.com\/pharmanews\/13709\/. Accessed April 10, 2019."},{"key":"zoi190168r12","unstructured":"NakazawaA, AustinS. New law on clinical trials (Japan). Practical Law. https:\/\/uk.practicallaw.thomsonreuters.com\/w-008-0908?transitionType=Default&contextData=(sc.Default)&firstPage=true&comp=pluk&bhcp=1. Accessed April 10, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/article-pdf\/2\/5\/e193817\/17711650\/sawano_2019_oi_190168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T11:00:43Z","timestamp":1563534043000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2733427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.3817","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]}}}